Nitric oxide (NO) produces rapid osteoclast detachment and contraction in vitro, and this effect is accompanied by a profound inhibition of bone resorption. Work by others has confirmed these findings in vivo: inhibition of NO synthase [NOS; L-arginine, NADPH: oxygen oxidoreductase (NO-forming), EC 1.14.13.39] in normal rats is followed by increased bone resorption reflected by a marked loss in bone mineral density. In our present study, immunocytochemistry and Northern blotting show the presence of the constitutive calcium-sensitive NOS isoform (cNOS) in normal rat osteoclasts and in the human preosteoclast cell line (FLG 29.1 by normal rat osteoclasts treated with LPS or IFN-'y. In contrast, the nonselective NOS inhibitor NG-monomethyl-Larginine inhibits resorption by untreated neonatal rat osteoclasts. Thus, osteoclast function may require intermittent calcium-stimulated increases in NO production by cNOS against a basal inhibitory background activity of the iNOS isoform. However, bone resorption depends on precursor replication and on the activity of the mature cells, and we found that the NO donor 3-morpholinosydnonimine (SIN-1) (50 ,uM) profoundly depressed replication in the human preosteoclast line. Taken together, these results strongly suggest that NO maintains a central control of bone resorption in both avian and mammalian species by exerting a powerful tonic restraint of osteoclast numbers and activity. The presence of NOS in human cells implies a similar function in man and that conventional views of calcium homoeostasis and skeletal metabolism will need substantial revision. Since NO also influences behavior of the osteoblast, the boneforming cell, in vitro, a similar effect in vivo might imply a general influence on bone remodeling.
strable in the rat cells especially after treatment with y interferon (IFN-,y) and bacterial wall products [lipopolysaccharide (LPS)], while a basal level of transcript was detected in the untreated human preosteoclast line. However NADPHdiaphorase activity was intense only in neonatal rat osteoclasts attached to bone, perhaps reflecting either enhancement of cNOS activity by calcium or increased amounts of the inducible isoform in activated osteoclasts in situ compared with isolated neonatal rat osteoclasts. These actively resorb devitalized bone but the untreated cells contain relatively low levels of NOS; they are extremely sensitive to inhibition by NO. The iNOS inhibitor aminoguanidine markedly enhances in vitro resorption by activated NOS-rich chick osteoclasts and by normal rat osteoclasts treated with LPS or IFN-'y. In contrast, the nonselective NOS inhibitor NG-monomethyl-Larginine inhibits resorption by untreated neonatal rat osteoclasts. Thus, osteoclast function may require intermittent calcium-stimulated increases in NO production by cNOS against a basal inhibitory background activity of the iNOS isoform. However, bone resorption depends on precursor replication and on the activity of the mature cells, and we found that the NO donor 3-morpholinosydnonimine (SIN-1) (50 ,uM) profoundly depressed replication in the human preosteoclast line. Taken together, these results strongly suggest that NO maintains a central control of bone resorption in both avian and mammalian species by exerting a powerful tonic restraint of osteoclast numbers and activity. The presence of NOS in human cells implies a similar function in man and that conventional views of calcium homoeostasis and skeletal metabolism will need substantial revision. Since NO also influences behavior of the osteoblast, the boneforming cell, in vitro, a similar effect in vivo might imply a general influence on bone remodeling.
Nitric oxide, or NO, secreted by the endothelium exerts an overriding control of blood pressure and blood flow by producing a dominant tonic dilatation of arterial muscle. To this crucial physiological role is added a number of other important functions. In the central nervous system, NO potentiates long-term memory; in the periphery it is the transmitter in the nonadrenergic noncholinergic (NANC) inhibitory nerves of the gastrointestinal and urogenital tracts. In contrast, the macrophage uses NO to kill invading microorganisms. NO is produced by several NO-synthase [NOS; L-arginine, NADPH: oxygen oxidoreductase (NO-forming), EC. 1.14. 13 .39] isoforms that require the same cofactors but vary in their response to calcium, mode of regulation, and tissue specificity (1) . Constitutive isoforms of NOS have been identified in brain (2) and endothelium (3), while in macrophages (4) and hepatocytes (5) NOS transcripts of inducible NOS (iNOS) isoforms are detected only after treatment with cytokines or lipopolysaccharide (LPS). However, this gas radical now appears to be involved in still another function-that of control of osteoclastic activity. The osteoclast is the only cell in the body that can resorb bone and, together with the kidney, this cell plays the major role in calcium homoeostasis, including the regulation of plasma calcium whose constancy is essential for health and even survival.
Calcitonin is the main circulating regulator, although estrogen and parathyroid hormone also have major effects. Our earlier studies (6) demonstrated that NO can produce rapid changes in osteoclast shape and motility and that these effects are accompanied by a profound inhibition of bone resorption. Using immunocytochemistry and RNA (Northern) blotting, we show here that the normal rat osteoclast and a human preosteoclast cell line (FLG 29.1) contain both calciumsensitive NOS (cNOS) and iNOS. Increased amounts of osteoclast iNOS follow stimulation by y interferon (IFN-,y) or LPS. Paradoxically, despite the abolition of bone resorption by NO gas or NO donors and its enhancement by iNOS inhibitors in NOS-rich chick osteoclasts, the nonspecific synthase inhibitor NG-monomethyl-L-arginine (LNMA) can impair resorption of bone slices by isolated neonatal rat osteoclasts, suggesting a minimal basal requirement for the gas radical. Finally, since osteoclast numbers are as important for resorptive effect as changes of short-term activity, we studied the effect of 3-morpholinosydnonimine (SIN-1) on replication of the human preosteoclast cell line: the NO donor strongly inhibited replication. Clearly, NO depresses the number and the activity of the osteoclasts. This effect may be of special importance in long-term studies. Our original prediction of a dominant tonic inhibitory restraint by NO of osteoclastic bone resorption is strongly supported by our present studies and further confirmed by recent in vivo studies in normal rats in which the iNOS inhibitor, aminoguanidine, induced marked bone loss (7) . 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (8) . The cells were maintained in RPMI-1640 medium supplemented with 10% (vol/vol) fetal calf serum, gentamycin (100 ,ug/ml), penicillin (100 units/ml), and streptomycin (100 ,g/ ml) in a humidified atmosphere of 10% C02/90% air at 37°C. Osteoclasts were disaggregated by curetting femora and tibiae obtained from newborn Sprague-Dawley rats in medium 199 with vigorous agitation (9) . The cells were suspended in 199 medium supplemented with 10% fetal calf serum, penicillin (100 units/ml), and streptomycin (100 ,ug/ml) before use in the bone-slice resorption assays or in videomicroscopic motility studies.
Endotoxin Treatment. Newborn Sprague-Dawley rats (n = 4) were injected intraperitoneally either with 20 mg of LPS per kg of body weight dissolved in pyrogen-free physiological saline or with vehicle only (n = 4, controls). Six hours later the rats were killed, and the hind limbs were removed and fixed in 1% paraformaldehyde for 6 hr. The tissues were frozen and stored for subsequent NADPH-diaphorase and immunocytochemical analyses after several washes in phosphate-buffered saline containing 15% sucrose and 0.01% sodium azide.
NADPH-Diaphorase Histochemistry. Sections of newborn rat hind limbs or osteoclasts isolated from them were fixed in 1% paraformaldehyde for 15 min before immersion for 45 min at 37°C in a solution of 50 mM Tris HCl buffer (pH 7.4) containing 1 mM B3-NADPH, 0.5 mM nitro blue tetrazolium, 1.5 mM L-malic acid, and 0.1% Triton X-100. This procedure resulted in intense nitro blue tetrazolium formazan staining absent when NADPH was omitted.
Immunocytochemistry and Antisera. Rat osteoclasts (at least 10 cells per well) were plated onto eight-well microscope slides coated with S ,tg of fibronectin per ml and incubated for 24 hr with or without IFN--y (50 ng/ml) and LPS (10 ,ug/ml) before fixation with 1% paraformaldehyde for 15 min. FLG 29.1 cells were centrifuged onto glass slides, followed by identical incubation and fixation. Polyclonal antisera for the cNOS and iNOS isoforms used in this study have been described in detail elsewhere (10, 11) . The cNOS antisera consisted of (i) a polyclonal antiserum raised against the whole protein purified from rat brain cross-reactive with both the endothelial and neuronal cNOS isoforms (10, 12) and (ii) a monoclonal antiserum raised against the endothelial isoform of cNOS (11) . Antiserum for iNOS was raised against a synthetic peptide (fragment 49; position 47-71) of murine macrophage iNOS (12) . Two different immunocytochemical methods were used to obtain conditions for image reconstructions of the complex osteoclast cell structure. The avidinbiotin-horseradish peroxidase method was used for the tissue sections and initially for cell cultures. An indirect immunofluorescence method was used for reconstructions of isolated cells with a Bio-Rad MRC-600 laser-scanning confocal microscope. In addition optical sections were taken at 1-,um intervals and acquired on a Nikon inverted microscope with a focus driver (Ludl Electronic, Hawthorne, NY). Out-of-focus information was removed by the method of Castleman (13) (15) . Briefly, Griess reagent (100 ,ul) consisting of 1% sulphanilamide and 0.1% N-1-naphthylethylenediamine dihydrochloride in 2% phosphoric acid was mixed with 100 ,ul of cell culture supernatant. Absorbance was then measured at 540 nm, and nitrite concentrations were determined from a standard curve.
Measurement of Osteoclast Spread Area. Osteoclast movement and attachment are reflected by changes in position and cell-spread area (16) . The suspension of normal neonatal rat osteoclasts was added to a 35-mm culture dish and allowed to sediment in a humidified atmosphere of 5% C02/95% air at 37°C; after 20 min nonattached cells were removed by washes with 199 medium, and the incubation was continued for a further 2 hr. The dishes were placed in a chamber attached to an inverted phase-contrast microscope (Diaphot; Nikon), and typical osteoclasts, with more than 4 nuclei, were selected for image analysis. Cell images were captured every 5 min from a charge-coupled video camera (TK-1085; JVC) interfaced to an Argus-10 image-processing system (Hamamatsu Photonics, Enfield, U.K.), which allowed measurement of cell area. Alternatively VOXELVIEW software on a Silicon Graphics Personal Iris workstation was used to measure the areas of stored cell images. Statistical analysis and plotting were performed on a NeXT workstation using DAN software (Triakis, Los Alamos, NM).
Measurement of Osteoclastic Bone Resorption. The ability of osteoclasts to resorb bone was assessed by the bone-slice assay originally described by Chambers and coworkers (17) , with some modifications. Squared slices (5 x 5 x 0.1 mm) of cortical bone were prepared from rat long bones with a low-speed saw. The slices were ultrasonicated for 15 min to clean their surfaces and then were sterilized, dehydrated in acetone for 10 min, rinsed in ethanol, and air dried before use. To avoid any significant loss of osteoclasts, sets of 9 bone slices were tightly fitted in 20-mm2 Petri dish compartments and preincubated in MEM for 1 hr at 37°C in 5% C02/95% air. The osteoclast suspension obtained from one rat was applied to a total of 18 slices. The suspension was allowed to sediment for 20 min on the bone slices, and the unattached osteoclasts were washed away with MEM medium. Each slice was then placed in a well of a 24-multiwell dish containing 0.5 ml of MEM and the compounds to be tested. After 18 hr of incubation, the bone slices were treated with a sodium hypochlorite solution (10% vol/vol), washed with distilled water, dehydrated, and dried. Gold sputter-coating was used as a conductive coating material to enable imaging of the specimens by scanning electron microscopy (Stereoscan 180; Cambridge Scientific Instruments, Cambridge, MA). The number of excavation pits was counted for each slice, and the pit area was recorded. To minimize random fluctuations, the experiments were analyzed only when the average number of excavations on the control bone slices (untreated cultures) exceeded 100. The resorbed area on the bone surface was calculated as the sum of the areas of individual excavations and expressed as a percentage of control values. The number of excavated pits was also recorded.
Cell 
RESULTS
Histochemistry, Immunocytochemistry, RNA Analysis, and Nitrite Production. NOS activity, as intense NADPHdiaphorase staining, was evident in rat osteoclasts in bone in situ. However, staining was greatly reduced in osteoclasts isolated on glass slides. Further, antisera specific for cNOS stained both isolated neonatal rat osteoclasts and the FLG 29.1 human cell lines (Fig. 1) . Three-dimensional reconstructions of the isolated rat osteoclasts stained with specific antisera for cNOS showed apparent localization of the synthase in the thick central perinuclear region of the cell and also on or near the cell membrane (Fig. 1) . Northern blots of RNA extracts from the FLG 29.1 preosteoclastic cell line provided definitive confirmation, showing a band with the expected molecular size of human cNOS (4 kb) and no difference in the amount of transcript between untreated and PMA-treated cells (Fig. 2) . The two faster migrating bands may be due to a differently spliced transcript of cNOS (3.8 kb) and to the cytochrome P-450 reductase mRNA (2 kb). Thus, while the 2-kb signal was still visible when using a full-length cDNA probe for human hepatocyte iNOS, neither the 4-kb nor the 3.8-kb transcript was seen. Further the 2-kb band was not detected by a 5'-end cDNA probe spanning nucleotides 831-1634 and having no homology with cytochrome P-450 reductase.
After stimulation by IFN-y or LPS, the iNOS isoform was clearly demonstrable by specific antisera in isolated neonatal rat osteoclasts and in bone-resorbing cells in situ (Fig. 1) . The presence of iNOS was also shown in the FLG 29.1 cells by immunocytochemistry (Fig. 1) , and its activity was evidenced by increased nitrite synthesis after addition of 100 units of IFN-,y per ml for 48 hr (1450 ± 189% of control, P < 0.0001). Further, we obtained definitive confirmation of the transcription of the iNOS isoform gene by using the reverse transcriptase-PCR technique (Fig. 2) . About 50 ng of cDNA synthesized from untreated and PMA-treated FLG 29.1 cells were utilized for PCR amplification with oligonucleotide primers deduced from the human hepatocyte iNOS cDNA. In differentiated (PMA-treated) FLG 29.1 cells, one of the amplified fragments consisted of 803 bp whose sequence was about 99% homologous with the corresponding iNOS region (Fig. 2) . We failed to detect any specific sequence with cDNA from untreated FLG 29.1 cells.
Functional Osteoclast Studies. Our previous studies showed that NO and NO donors produce a marked contraction and detachment of isolated rat osteoclasts (6). Here we show that, when isolated rat osteoclasts are suddenly exposed to an increased calcium level, they contract and detach from the underlying surface. This presumably reflects the calciumtriggered detachment in vivo which precedes osteoclast movement and reattachment to a new site. This sequence can be inferred from scanning electron microscopy views of osteoclasts on devitalized bone slices. However, the detachmentcontraction following exposure to calcium was delayed or Despite the inhibitory effect of NO donors, we found that, paradoxically, the nonspecific NOS inhibitor LNMA could also inhibit or abolish osteoclastic resorption of bone slices by isolated rat cells, suggesting a basal minimum requirement for NO in normal bone resorption (Fig. 4) . When neonatal rat osteoclasts are pretreated with LPS (1 ,ug/ml) for 18 hr before study, we found that 0.5-2.5 mM aminoguanidine produced a 220 ± 3% enhancement of osteoclastic resorption (P < 0.01), confirming the potent inhibitory role of the autacoid in 
DISCUSSION
It has been recognized for many years that the local microenvironment is central to the regulation of bone resorption. However, progress in defining the molecular and cellular basis of this control has been made only recently. For example, it is now known that a number of factors produced by osteoblasts modulate the proliferation and the differentiation of osteoclast precursors and the function of mature osteoclasts (reviewed in ref. 18 ). Many of these agents are cytokines. In addition, it has been reported that NO produced by osteoblasts inhibits the function of mature osteoclastic cells (6, 19) . Here we show that the osteoclasts themselves and their precursors also synthesize NO and that minimal quantities of the free radical are necessary for normal osteoclastic function. These observations, together with the effect of NO on the proliferation of preosteoclastic cells first described here, imply an important physiological role for the autacoid in the overall regulation of bone resorption. The recent results of Kasten et al. (7) confirm this prediction. They found that administration of the iNOS inhibitor, aminoguanidine, to normal and ovariectomized rats, led to marked bone loss in both groups.
In previous studies it has been shown that NOS can be induced by LPS and cytokines in osteoblasts and osteoblastlike cells and that this is accompanied by inhibition of bone resorption (6, 19) . This may reflect the situation in inflammatory bone and joint disease, where the simultaneous induction of iNOS may limit the bone destruction otherwise to be expected from osteoclast activation by inflammatory cytokines.
Despite this dominant inhibitory effect of NO on osteoclasts in vivo and in vitro, paradoxically LNMA can also decrease or abolish in vitro bone resorption, suggesting a basal minimum requirement for the radical for osteoclast function. Cyclic calcium-stimulated "puffs" of NO may be necessary for the transient osteoclast detachment and movement which are part of the normal bone resorption process.
The mechanism of NO inhibition of the osteoclast is still unclear. Kasten et al. (7) found that NO increased the concentration of cGMP in osteoclasts from calcium-deficient chicks, but we have been unable to reproduce with permeant analogues of cGMP any of the effects of NO on osteoclasts, either in videomicroscopy or on devitalized bone slices (6) . Preliminary studies (A. Cudd and I.M., unpublished data) suggested that the contractile osteoclast response to NO can be prevented by protein kinase C inhibitors, but further work is necessary to combine these observations in a satisfactory hypothesis. The demonstration here of the production of NO by osteoclast precursors together with the effects of NO donors on the proliferation of these preosteoclastic cells helps to explain the complex inhibitory effect of the gas radical on bone resorption. Thus, the inhibitory in vivo effects of NO are the resultant of its action both on mature osteoclasts and on their progenitors. The NO-induced decrease in the proliferation of osteoclast precursors is expected to reduce the ultimate number of resorbing osteoclasts and thus to be of importance in the long-term regulation of bone resorption. Further studies are needed to understand the place of NO in osteoclastogenesis, but it is clear that the basal transcription of both cNOS and iNOS genes in preosteoclasts strongly implies an important autocrine role in modulating osteoclast maturation.
Finally, it is quite clear from these studies that NO exerts a powerful physiological tonic restraint of osteoclastic bone resorption and that current views of bone cell regulation will have to be modified to accommodate these new findings. If, as seems possible, these findings apply to man, they present new targets for novel therapeutic agents capable of modifying excessive bone destruction in osteoporosis, malignant deposits in bone, and rheumatoid arthritis.
